When and how to use predictive biomarkers for corticosteroid treatment of septic shock

被引：3
作者：
Russell, James A. [1 ,2 ,3 ]
机构：
[1] St Pauls Hosp, Ctr Heart Lung Innovat, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
[3] Div Crit Care Med, Vancouver, BC V6Z 1Y6, Canada
来源：
CRITICAL CARE | 2018年 / 22卷
关键词：
Septic shock; Predictive biomarkers; Gene expression; Leukocyte; PLASMA CYTOKINE LEVELS; NOREPINEPHRINE; VASOPRESSIN; SEPSIS; FLUDROCORTISONE; HYDROCORTISONE; GUIDELINES; MANAGEMENT; MORTALITY;
D O I：
10.1186/s13054-018-2254-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Biomarkers for pediatric sepsis and septic shock
    Standage, Stephen W.
    Wong, Hector R.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (01) : 71 - 79
  • [32] Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy, Bruno
    Buzon, Julie
    Kimmoun, Antoine
    CURRENT OPINION IN CRITICAL CARE, 2019, 25 (04) : 384 - 390
  • [33] NORMAL-RANGE BLOOD LACTATE CONCENTRATION IN SEPTIC SHOCK IS PROGNOSTIC AND PREDICTIVE
    Wacharasint, Petch
    Nakada, Taka-aki
    Boyd, John H.
    Russell, James A.
    Walley, Keith R.
    SHOCK, 2012, 38 (01): : 4 - 10
  • [34] Current use of vasopressors in septic shock
    Thomas W. L. Scheeren
    Jan Bakker
    Daniel De Backer
    Djillali Annane
    Pierre Asfar
    E. Christiaan Boerma
    Maurizio Cecconi
    Arnaldo Dubin
    Martin W. Dünser
    Jacques Duranteau
    Anthony C. Gordon
    Olfa Hamzaoui
    Glenn Hernández
    Marc Leone
    Bruno Levy
    Claude Martin
    Alexandre Mebazaa
    Xavier Monnet
    Andrea Morelli
    Didier Payen
    Rupert Pearse
    Michael R. Pinsky
    Peter Radermacher
    Daniel Reuter
    Bernd Saugel
    Yasser Sakr
    Mervyn Singer
    Pierre Squara
    Antoine Vieillard-Baron
    Philippe Vignon
    Simon T. Vistisen
    Iwan C. C. van der Horst
    Jean-Louis Vincent
    Jean-Louis Teboul
    Annals of Intensive Care, 9
  • [35] Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults A Randomized Controlled Trial
    Annane, Djillali
    Cariou, Alain
    Maxime, Virginie
    Azoulay, Elie
    D'honneur, Gilles
    Timsit, Jean Francois
    Cohen, Yves
    Wolf, Michel
    Fartoukh, Muriel
    Adrie, Christophe
    Santre, Charles
    Bollaert, Pierre Edouard
    Mathonet, Armelle
    Amathieu, Roland
    Tabah, Alexis
    Clec'h, Christophe
    Mayaud, Julien
    Lejeune, Julie
    Chevret, Sylvie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (04): : 341 - 348
  • [36] Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review
    Mandal, Naishal
    Kham, Nang I.
    Shahid, Rabia
    Naik, Shaili S.
    Ramphall, Shivana
    Rijal, Swarnima
    Prakash, Vishakh
    Ekladios, Heba
    Saju, Jiya Mulayamkuzhiyil
    Venugopal, Sathish
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [37] New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?
    Berry, Michael
    Patel, Brijesh V.
    Brett, Stephen J.
    DRUGS, 2017, 77 (04) : 353 - 361
  • [38] Corticosteroid therapy in patients with severe sepsis and septic shock
    Keh, D
    Goodman, S
    Sprung, CL
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 (06) : 713 - 719
  • [39] Is hydrocortisone an effective treatment for septic shock?
    Cooper, Mark S.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (07): : 368 - 369
  • [40] Total and high-affinity corticosteroid-binding globulin depletion in septic shock is associated with mortality
    Meyer, Emily J.
    Nenke, Marni A.
    Rankin, Wayne
    Lewis, John G.
    Konings, Elisabeth
    Slager, Maarten
    Jansen, Tim C.
    Bakker, Jan
    Hofland, Johannes
    Feelders, Richard A.
    Torpy, David J.
    CLINICAL ENDOCRINOLOGY, 2019, 90 (01) : 232 - 240
12345